Carcereny E, Felip E, Reck M, et al. Updated Efficacy Results From the BIRCH Study: First-Line Atezolizumab Therapy in PD-L1–Selected Patients With Advanced NSCLC. 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 17.02.
Op zoek naar de perfecte dosis carboplatine bij longkanker
feb 2024 | Borstkanker, Gynaecologische oncologie, Longoncologie